This funding opportunity supports fundamental research aimed at understanding skin injuries caused by chemical threats identified as public health risks. It emphasizes investigating common injury mechanisms and signaling pathways to identify potential therapeutic targets for medical countermeasure development. Clinical trials are not allowed under this initiative.
Eligible applicants include a wide range of U.S. organizations such as public housing authorities, nonprofits, tribal governments, educational institutions, and government entities. Foreign organizations are generally not eligible, but foreign components of U.S. organizations are allowed.
